| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 28.09. | Lilly's Olumiant OKed by FDA for Pediatric Patients Over 12 with Severe Alopecia Areata | ||
| 28.09. | Thermo Fisher Launches Nicolet RaptIR X FTIR Microscope | ||
| 28.09. | FDA Approves AbbVie's Juvmo for Parkinson's Disease | ||
| 28.09. | Gates Foundation Extends Funding for AN2 Therapeutics, GSK Research Collab | ||
| 28.09. | Eutecma Buys Tempaid in Cold Chain Packaging Deal | ||
| 28.09. | AGC Biologics to Manufacture Flen Health Wound-Care Enzymes | ||
| 28.09. | Vetter Expands Fill-Finish Capacity | ||
| 25.09. | Contract Pharma 2026 Conference Concludes with Risk Management Forum | ||
| 25.09. | SK pharmteco Launches Catalyst Kit | ||
| 25.09. | Recipharm, CanVirex Partner on Oncolytic Virus Manufacturing | ||
| 23.09. | Cellares, SNUH Partner on Cell Therapy Manufacturing | ||
| 23.09. | AustinPx KinetiSol Earns FDA AMT Designation | ||
| 23.09. | Contract Pharma Announces New Bio Outsourcing Conference in Cambridge | ||
| 23.09. | Astoriom Acquires Roylance Stability Storage and Roylance Scientific | ||
| 22.09. | Longhorn Vaccines and Diagnostics Names Dr. Vijay Singh Chief Scientific Officer | ||
| 22.09. | James Alexander Corporation Becomes 100% Employee-Owned | ||
| 22.09. | ExploRNA, Åukasiewicz Research Network Partner on GMP Manufacturing of Next-Gen mRNA Cap Analogs | ||
| 22.09. | Sanner Rebrands Gilero, Expands Chicago Facility | ||
| 22.09. | Travere Therapeutics Names Bradley Campbell CEO | ||
| 22.09. | Lilly Breaks Ground on $6.5B Houston Manufacturing Site | ||
| 21.09. | FDA Approves IntraBio's Aqneursa as First Treatment for Ataxia-Telangiectasia | ||
| 21.09. | Mirum Pharmaceuticals Names Rob Myers Chief Medical Officer | ||
| 21.09. | Codis Promotes Steven Facer to Chief Commercial Officer | ||
| 21.09. | WuXi XDC Secures GMP Release for Singapore Manufacturing Site | ||
| 21.09. | Telix to Buy ITM in $1.65B Radiopharma Deal |